Back to home


February 2021/RESP-807(1)



Full prescribing information available here


JANUARY 2021 / RESP-765(1)


Adverse events should be reported. Reporting forms and information can be found at Adverse events should also be reported to Orion Pharma (UK) Ltd on 01635 520300.

Orion Pharma (UK) Ltd, Oaklea Court, 22 Park Street, Newbury, Berkshire RG14 1EA UK | Tel: +44 1635 520 300 Date of Preparation: October 2019 / RESP-330
Policies Contact us Orion Corporation 2021